In fact, among the top ten AD risk genes conferring small effects, CD33 was the only one that showed significant effects in combination with APOE ε4 allele, suggesting that the impact of CD33 on AD susceptibility can be more profound when combined with other major risk factors [10]. This evidence concerns the gene APOE and Alzheimer disease.